Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the Optimum Delivery Route for the Intraglandular Administration of Botulinum Toxin A in Patients With Refractory Epiphora

NCT01282541 is registered in ClinicalTrials.gov with Merbs, Shannath, M.D., Ph.D. as lead sponsor.

NCT NCT01282541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01282541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the Optimum Delivery Route for the Intraglandular Administration of Botulinum Toxin A in Patients With Refractory Epiphora
Lead sponsor
Merbs, Shannath, M.D., Ph.D.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2011
Completion date
September 30, 2012
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epiphora